In Stock

• Effective substance: Boldenone undecylenate
  
• Content: 250 mg/ml
• BOX: with 1x 10ml vial
  
• Administration:  intramuscular injection
• Known as: bolde, equipoise

Boldenone (INN, BAN), also known as Δ1-testosterone, 1-dehydrotestosterone, or androsta-1,4-dien-3-one-17β-ol, is a synthetic anabolic-androgenic steroid (AAS) and the 1(2)-dehydrogenated analogue of testosterone. Boldenone itself has never been marketed; as a pharmaceutical drug, it is used as boldenone undecylenate, the undecylenate ester.

 This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2009) (Learn how and when to remove this template message)

The activity of boldenone is mainly anabolic, with a low androgenic potency. Boldenone will increase nitrogen retention, protein synthesis, increases appetite and stimulates the release of erythropoietin in the kidneys. Boldenone was synthesized in an attempt to create a long-acting injectable methandrostenolone (Dianabol), for androgen deficiency disorders. Boldenone acts similar to methandrostenolone with fewer adverse androgenic effects.[medical citation needed] Although commonly compared to nandrolone, boldenone lacks progesterone receptor interaction and all the associated progestogenic side effects.

Bolde 250, featuring the active ingredient Boldenone Undecylenate, primarily serves as a supportive medication in veterinary treatments. Unlike its counterpart Dianabol, Bolde 250 lacks the 17-alpha-methyl group.

With potent anabolic and androgenic effects, Bolde 250 exhibits lower estrogenic and no progestogenic activity. Remarkably, it carries no risk of hepatotoxicity and boasts a longer carbon atom chain compared to decanoate. Other characteristics align closely with typical anabolic androgenic steroids.

One of Bolde 250's key advantages lies in its non-aromatizing nature and absence of progestogen activity. This translates to minimal water retention, estrogen production, and significantly reduces the risk of gynecomastia when used according to prescribed regimens.

Featuring a half-life of 14 days and based on testosterone, Bolde 250 offers sustained benefits over an extended period.